From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

tepilamide fumarate   Click here for help

GtoPdb Ligand ID: 9770

Synonyms: XP 23829 | XP-23829 | XP23829
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Tepilamide fumarate (XP23829) is a small-molecule fumaric acid ester prodrug of monomethyl fumarate (MMF). It is being developed by Arbor Pharmaceuticals (formerly XenoPort) as a potential treatment for autoinflammatory diseases.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 0
Rotatable bonds 9
Topological polar surface area 72.91
Molecular weight 243.11
XLogP 0.39
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN(C(=O)COC(=O)C=CC(=O)OC)CC
Isomeric SMILES CCN(C(=O)COC(=O)/C=C/C(=O)OC)CC
InChI InChI=1S/C11H17NO5/c1-4-12(5-2)9(13)8-17-11(15)7-6-10(14)16-3/h6-7H,4-5,8H2,1-3H3/b7-6+
InChI Key AKUGRXRLHCCENI-VOTSOKGWSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
XP23829 has completed a Phase 2 clinical trial in patients with moderate-to-severe chronic plaque-type psoriasis (see NCT02173301). It has also been suggested as a treatment for relapsing-remitting multiple sclerosis, given approval of another MMF prodrug, dimethyl fumarate, for MS.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02173301 A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis Phase 2 Interventional XenoPort, Inc.